Life Saving Drugs Program – Perinatal- or infantile-onset hypophosphatasia (HPP) – Reapplication

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for HPP.

This form includes:

  • patient eligibility checklist
  • privacy notice and patient consent
  • dosing details
  • treating physician’s declaration
  • reapplication checklist.

Life Saving Drugs Program – Perinatal- or infantile-onset hypophosphatasia (HPP) – Reapplication

About this resource

Publication date:
Publication type:
Form
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.